Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues

被引:2
|
作者
Vieira de Ribeiro, Ana Julia [1 ]
Sandim, Vanessa [1 ]
Ornellas, Antonio Augusto [2 ,3 ]
Reis, Rodrigo Siqueira [4 ]
Domont, Gilberto [4 ]
Alves, Gilda [1 ]
机构
[1] Inst Nacl Canc, Appl Genet Lab, Div Hematol, BR-20230130 Rio De Janeiro, RJ, Brazil
[2] Inst Nacl Canc, Div Urol, BR-20230130 Rio De Janeiro, RJ, Brazil
[3] Hosp Mario Kroeff, Div Urol, Rio De Janeiro, RJ, Brazil
[4] Univ Fed Rio de Janeiro, Inst Chem, Prote Unit, BR-21941 Rio De Janeiro, RJ, Brazil
来源
INTERNATIONAL BRAZ J UROL | 2013年 / 39卷 / 01期
关键词
Carcinoma; Renal Cell; Proteome; Electrophoresis; Polyacrylamide Gel; Kidney; OXIDATIVE STRESS; MESSENGER-RNA; CANCER-CELLS; IDENTIFICATION; EXPRESSION; PROHIBITIN; BIOMARKER;
D O I
10.1590/S1677-5538.IBJU.2013.01.11
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We attempted to detect, for the first time in a Brazilian cohort, differences in protein expression between clear-cell renal cell carcinoma (ccRCC) and their normal adjacent tissues, aiming to identify biomarkers and/or therapeutic target candidates for this disease. Material and Methods: Twenty-four ccRCC and adjacent normal tissues were collected after surgery and their protein extracts were quantified, pooled and separated by two-dimensional polyacrylamide gel electrophoresis (2DE), followed by statistical analysis of the stained gels. Spots of interest were excised from the gels, digested with trypsin and identified by MALDI-TOF-TOF mass spectrometry. Results: Twenty-six differential spots were detected between the two classes of tissues, among which twenty were identified by mass spectrometry and sixteen were found to be non-redundant. Eleven proteins were either underexpressed or undetected in the ccRCC extracts, such as prohibitin and peroxiredoxin-3, whereas five were found to be overexpressed or exclusively detected in the ccRCC extract, including alpha beta crystalin and heat shock protein 27. Conclusions: Several proteins were detected at differential levels when compared to normal adjacent tissues, and, moreover, many have been previously described by their relationship with RCC. Therefore, this work corroborates previous reports on the search for biomarkers for ccRCC, as well as it points out new candidates that may be validated in future studies.
引用
收藏
页码:83 / 94
页数:12
相关论文
共 50 条
  • [21] Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma
    Fu, Hangcheng
    Liu, Yidong
    Xu, Le
    Liu, Weisi
    Fu, Qiang
    Liu, Haiou
    Zhang, Weijuan
    Xu, Jiejie
    TUMOR BIOLOGY, 2015, 36 (08) : 5791 - 5799
  • [22] Ribonucleotide reductase subunit M2 as a novel target for clear-cell renal cell carcinoma
    Zou, Yun
    Zhou, Juan
    Xu, Bin
    Li, Wenzhi
    Wang, Zhong
    ONCOTARGETS AND THERAPY, 2019, 12 : 3267 - 3275
  • [23] Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)
    Bielecka, Zofia F.
    Czarnecka, Anna M.
    Solarek, Wojciech
    Kornakiewicz, Anna
    Szczylik, Cezary
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2013, 8 (03) : 219 - 228
  • [24] Lamin-B1 is a senescence-associated biomarker in clear-cell renal cell carcinoma
    Radspieler, Melissa Marie
    Schindeldecker, Mario
    Stenzel, Philipp
    Foersch, Sebastian
    Tagscherer, Katrin E.
    Herpel, Esther
    Hohenfellner, Markus
    Hatiboglu, Gencay
    Roth, Wilfried
    Macher-Goeppinger, Stephan
    ONCOLOGY LETTERS, 2019, 18 (03) : 2654 - 2660
  • [25] Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma
    Sonpavde, Guru
    Willey, Christopher D.
    Sudarshan, Sunil
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (03) : 305 - 315
  • [26] Identifying an Inversin as a Novel Prognostic Marker in Patients with Clear-Cell Renal Cell Carcinoma
    Urlic, Ivanka
    Soljic, Violeta
    Vukoja, Martina
    Marijanovic, Inga
    Kraljevic, Marija
    Urlic, Marjan
    Maric, Sara
    Vukojevic, Katarina
    Filipovic, Natalija
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [27] Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinoma
    Jespersen, Jesper
    Lindgaard, Cecilie
    Iisager, Laura
    Ahrenfeldt, Johanne
    Lyskjaer, Iben
    NATURE REVIEWS UROLOGY, 2025,
  • [28] MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma
    Kinget, Lisa
    Roussel, Eduard
    Lambrechts, Diether
    Boeckx, Bram
    Vanginderhuysen, Loic
    Albersen, Maarten
    Rodriguez-Antona, Cristina
    Grana-Castro, Osvaldo
    Inglada-Perez, Lucia
    Verbiest, Annelies
    Zucman-Rossi, Jessica
    Couchy, Gabrielle
    Caruso, Stefano
    Laenen, Annouschka
    Baldewijns, Marcella
    Beuselinck, Benoit
    CANCERS, 2021, 13 (07)
  • [29] DHH is an Independent Prognosticator of Oncologic Outcome of Clear Cell Renal Cell Carcinoma
    Jaeger, Wolfgang
    Thomas, Christian
    Fazli, Ladan
    Hurtado-Coll, Antonio
    Li, Estelle
    Janssen, Claudia
    Gust, Kilian M.
    So, Alan I.
    Hainz, Michael
    Schmidtmann, Irene
    Roos, Frederik C.
    Thueroff, Joachim W.
    Brenner, Walburgis
    Black, Peter C.
    JOURNAL OF UROLOGY, 2014, 192 (06) : 1842 - 1848
  • [30] Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers
    Li, Qing Kay
    Pavlovich, Christian P.
    Zhang, Hui
    Kinsinger, Christopher R.
    Chan, Daniel W.
    SEMINARS IN CANCER BIOLOGY, 2019, 55 : 8 - 15